Adenoviral insulinoma-associated protein 1 promoter-driven suicide gene therapy with enhanced selectivity for treatment of neuroendocrine cancers.
about
Progress and problems with the use of suicide genes for targeted cancer therapySafety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.Somatostatin receptor based imaging and radionuclide therapy.Suicide Gene Therapy for Cancer - Current Strategies.Expression of the insulinoma-associated 1 (insm1) gene in Xenopus laevis tadpole retina and brain.
P2860
Adenoviral insulinoma-associated protein 1 promoter-driven suicide gene therapy with enhanced selectivity for treatment of neuroendocrine cancers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Adenoviral insulinoma-associat ...... ent of neuroendocrine cancers.
@ast
Adenoviral insulinoma-associat ...... ent of neuroendocrine cancers.
@en
type
label
Adenoviral insulinoma-associat ...... ent of neuroendocrine cancers.
@ast
Adenoviral insulinoma-associat ...... ent of neuroendocrine cancers.
@en
prefLabel
Adenoviral insulinoma-associat ...... ent of neuroendocrine cancers.
@ast
Adenoviral insulinoma-associat ...... ent of neuroendocrine cancers.
@en
P2093
P2860
P921
P1433
P1476
Adenoviral insulinoma-associat ...... ent of neuroendocrine cancers.
@en
P2093
Chiachen Chen
Mary B Breslin
Michael S Lan
Victoria Akerstrom
P2860
P577
2013-01-01T00:00:00Z